Verinurad
| CAS No. | 1352792-74-5 | Cat. No. | BCP17058 |
| Name | Verinurad | ||
| Synonyms | RDEA3170;RDEA-3170;RDEA 3170; | ||
| Formula | C20H16N2O2S | M. Wt | 348.42 |
| Description | Verinurad, also known as RDEA3170, is an organic anion transporter URAT1 (SLC22A12) inhibitor, is being developed by Ardea Biosciences (a subsidiary of AstraZeneca) for the treatment of gout and hyperuricaemia. | ||
| Pathways | Ion Channel/Membrane Transporter | ||
| Targets | URAT1 | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.